Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
In a significant shift, recent findings indicate that statins, specifically simvastatin, may play a crucial role in enhancing cognitive function in dementia patients, challenging the traditional perception of their use.
Cardiology January 17th 2024
The Epoch Times
Emerging research suggests that statins, while beneficial in some respects, could potentially exacerbate coronary artery calcification and deplete vital heart-protecting nutrients.
Cardiology January 4th 2024
ACP Internist
The recent LODESTAR clinical trial has revealed that although the two statins are equally effective in preventing heart attacks, strokes, and death, one has been associated with a higher risk of developing type 2 diabetes and requiring cataract surgery.
Cardiology November 15th 2023
A recent study involving 4,400 participants revealed that two major statins—rosuvastatin and atorvastatin—are equally effective at reducing heart attacks, strokes, and all-cause deaths. However, it was found that the rosuvastatin group was more likely (7.2%) to develop type 2 diabetes than the atorvastatin group (5.3%).
Cardiology November 2nd 2023
British Medical Journal
This study provides valuable insights into the comparative benefits and risks of rosuvastatin and atorvastatin in adults with coronary artery disease. Notably, while both drugs showed comparable efficacy, rosuvastatin was associated with a higher risk of new onset diabetes mellitus and cataract surgery.
Cardiology October 25th 2023
Annals of Internal Medicine
A recent Danish cohort study reveals that older adults (≥75 years) may experience a more pronounced LDL-C reduction with low- to moderate-intensity statins than their younger counterparts. This finding emphasizes the need to consider age when prescribing statin therapy.
Cardiology August 9th 2023